Results 241 to 250 of about 223,917 (311)

Unravelling the Major Cardiovascular Risks of Systemic Psoriasis Medications: A Literature Systematic Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory dermatological condition associated with an elevated risk of cardiovascular events (CVEs). Systemic therapies have transformed disease management, but their cardiovascular (CV) safety profiles remain incompletely understood and inconsistently reported.
Mai Thi Hoai Son, Yves Julien Mbama Biloa, Pauline Gouttefarde, Thomas Franck, Gilles Cizeron, Mathieu Oriol, François Maccari, Elisa Cinotti, Beatrice Trombert‐Paviot, Bienvenu Bongue, Jean‐Luc Perrot   +10 more
wiley   +1 more source

Computer-Assisted Dynamic Contrast-Enhanced Magnetic Resonance Imaging Quantification Method for Assessment of Synovial Inflammation in Active Arthritis: Correlation With Synovial and Blood Biomarkers. [PDF]

ACR Open Rheumatol
Boesen M, Shakoor D, Kubassova O, Riis R, Bliddal H, Ballegaard C, Carrino JA, Bartels EM.   +7 more
europepmc   +1 more source

Applications and Challenges of Digital Health in Rheumatology

iNew Medicine, EarlyView.
Xiao‐Xiao Li, Xue‐Er Cheng, Ming‐Ming Zhang, Peng Wang, Hai‐Feng Pan   +4 more
wiley   +1 more source

Mendelian randomization identifies multiple immune cell surface markers as potential causal contributors and drug targets in rheumatoid arthritis. [PDF]

J Int Med Res
Huang G, Huang Y, Liao G, Xiao K, Li C, Gu R.   +5 more
europepmc   +1 more source

A Cross-Sectional Study on Elevated Serum Calcitonin Gene-Related Peptide Levels in Rheumatoid Arthritis Patients and Their Relationship with Disease Activity. [PDF]

Arch Rheumatol
Dede Akpınar M, Ataoğlu S, Cangür Ş.
europepmc   +1 more source

Salivary Zinc Levels in Rheumatoid Arthritis.

J Pharm Bioallied Sci
Sharma A, Arya A, Sharma CK, Gupta A, Sharma R, Shah M.   +5 more
europepmc   +1 more source